openPR Logo
Press release

Technology Evolution on Retinal Disease Therapeutics Market

01-24-2020 02:16 PM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd

Technology Evolution on Retinal Disease Therapeutics Market

The Global Retinal Disease Therapeutics Market is likely to expand at an impressive rate driven by recent government participation towards the prevention and control of retinal diseases. According to a report published by Fortune Business Insights, titled "Retinal Disease Therapeutics: Global Market Analysis, Insights, and Forecast, 2019-2026," the market is likely to reach US$ 21,318.0 Mn by the end of 2026. The market was valued at US$ 11,044.2 Mn in 2018 and is likely to witness a CAGR of 8.6% in the forecast period.

The report covers:

o Global Retinal Disease Therapeutics Market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast timeframe.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/retinal-disease-therapeutics-market-100311

Leading Players operating in the Retinal Disease Therapeutics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Merck
o Novartis
o Allergan
o Roche
o Regeneron Pharmaceuticals, Inc.
o Santen Pharmaceutical

North America to Emerge Dominant in the Forecast Period

The increasing government investment towards research and development of retinal disease drugs and diagnostic devices is enabling growth in the retinal diseases therapeutics market in North America. North America has emerged dominant in the global retinal disease therapeutics market in recent years. The Retinal Disease Therapeutics Market in North America was valued at US$ 4056.5Mn in 2018 and is likely to increase in the coming years.

Improved health infrastructures, increasing patient pool, and favorable health reimbursement policies are some of the factors that are likely to boost the regional market in the forthcoming years. High prevalence of retinal diseases in the Asia Pacific is a major reason why this region is estimated to rise with the highest CAGR in the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/retinal-disease-therapeutics-market-100311

F. Hoffmann-La Roche AG's 'Lucentis' is Gaining Increasing Popularity

The diabetic retinopathy is a severe kind of disorder that has accounted for the majority of cases of blindness in the US. Lucentis was an instant hit among healthcare professionals after it was backed by a series of clinical trials and approvals from the National Institute of Health (NIH).

One such instance of this development is the "Lucentis" therapy, put forward by F. Hoffmann-La Roche AG. Lucentis was introduced to provide therapeutic advice and development of products for patients suffering from chronic disease. In 2017, the Food and Drug Administration (FDA) approved Lucentis for diabetic retinopathy.

Detailed Table of Content:

o Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
o Executive Summary
o Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Key Insights
o Recent industry developments such as mergers & acquisitions
o Regulatory scenario for key countries
o Prevalence of Key Retinal Diseases, in Major Countries
o Pipeline Analysis
o Patent Snapshot
o Global Retinal Disease Therapeutics Market Analysis, Insights and Forecast, 2015-2026
o Key Findings / Summary
o Market Analysis, Insights and Forecast - By Disease Indication
? Macular Degeneration
? Diabetic Macular Edema
? Diabetic Retinopathy
? Retinal Vein Occlusion
? Others
o Market Analysis, Insights and Forecast - By End User
? Hospital Pharmacy
? Retail Pharmacy
? Others
o Market Analysis, Insights and Forecast - By Region
? North America
? Europe
? Asia Pacific
? Latin America
? Middle East & Africa
o North America Retinal Disease Therapeutics Market Analysis, Insights and Forecast, 2015-2026

Report Focus:

o Extensive product offerings
o Customer research services
o Robust research methodology
o Comprehensive reports
o Latest technological developments
o Value chain analysis
o Potential Retinal Disease Therapeutics Market opportunities
o Growth dynamics
o Quality assurance
o Post-sales support
o Regular report updates

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Technology Evolution on Retinal Disease Therapeutics Market here

News-ID: 1908037 • Views: 81

More Releases from Fortune Business Insights Pvt. Ltd

What's driving the Contraceptive Pills Market Growth? Prominent Players: Janssen …
The global "contraceptive pills market" size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed
Why the Contact Lenses Market is set to explode? Top Companies: Contamac, Cooper …
The global contact lenses market size is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period. However, the market was worth USD 8.35 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, "Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail
Vaccines Market by Top Key Players are GlaxoSmithKline plc., Sanofi, Pfizer Inc. …
The global "Vaccines Market Size" is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% during the forecast period. The growing prevalence of malaria around the world is a key factor boosting the vaccines market. According to the World Health Organization, in 2017, there were an estimated 219 million cases of malaria in 87 countries. Total funding for malaria control and elimination reached an estimated US$
What is Driving the Plasma Fractionation Market by Top Key Players: Grifols, Bax …
The "plasma fractionation market size" is anticipated to reach USD 38.65 Billion by 2026. Increasing number of patients with congenital disorders, along with rising research and development (R&D) activities, will drive the market. Fortune Business Insights has published a report, titled "Plasma Fractionation Market Size, Share & Industry Analysis, By Product Type (Albumin, Immunoglobulin (Intravenous Immunoglobulin and Subcutaneous Immunoglobulin), Coagulation Factors (Factor IX, Factor VIII, Prothrombin Complex Concentrates, Fibrinogen concentrates

All 5 Releases


More Releases for Retinal

Retinal Biosimilars Market Opportunity by 2026
The retinal biosimilars market has witnessed a remarkable boost with the approval of several retinal biosimilars in 2017. Amgen’s Amgevita in March, f Biogen/Samsung Bioepis’s Imraldi in August, and Boehringer Ingelheim Internationl’s Cyltezo in November were approved in their respective regions. The slow adoption of retinal biosimilars is anticipated due to the initial reluctance of physicians to prescribe retinal biosimilars for individuals who have been using branded products over a
Global Retinal Implants Market 2018 - Centrasight, Retinal Implant, Boston Retin …
Eminent Market Reports, recently published a detailed market research study focused on the “Retinal Implants Market” across the global, regional and country level. The report provides 360° analysis of “Retinal Implants Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Retinal Implants on
Retinal Disorders – Therapy Market Snapshot
Boston, MA ReportsWorldwide has announced the addition of a new report title Retinal Disorders – Therapy Market Snapshot to its growing collection of premium market research reports. A range of disorders, some of which share similar underlying pathologies, can affect the retina and lead to progressively worsening vision and eventual blindness. The retina is the layer of light-sensitive tissue at the back of the eye that converts light into impulses to the
Retinal Surgery Devices Market: Regional & Competitive Analysis
As per the statistical analysis of TMR, a revenue valuation of around US$2.01 bn has been anticipated to be obtained by the global retinal surgery devices market in 2020. Despite holding a king’s share for retinal surgery devices in the recent past, vitrectomy packs could showcase a faster growth during the course of the forecast period. According to regional analysis, North America could take the driver’s seat while operating at
Retinal Surgery Devices Market Outlook
Retinal surgery devices are undergoing rapid technological advancement to establish an effective treatment platform for various retinal diseases. For instance, minimally invasive surgical instruments for the treatment of retinal diseases offer advantages such as lesser pain, minor scarring, quick recovery and reduced health care costs. Applications of retinal surgery devices across various ophthalmic conditions such as diabetic retinopathy, retinal detachment, epiretinal membrane and macular hole are driving the growth of
Retinal Implants Sales Market Report 2017: Second Sight, Boston Retinal Implant …
In this report, the global Retinal Implants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request for sample of Retinal Implants Market research report @ https://www.qyresearchgroups.com/request-sample/364879 Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Retinal